Pituitary-directed drugs directly target the corticotroph pituitary tumor, which represents the origin of the disease and the source of the excessive ACTH production causing the adrenal cortisol excess, and consequently aim at the normalization of cortisol secretion through the control of the excessive ACTH secretion and the shrinkage of the pituitary tumor (4). Here, POMC is linked to pituitary tumor.